Incyte Corporation
DIHYDROPYRIDO[2,3-D]PYRIMIDINONE COMPOUNDS AS CDK2 INHIBITORS
Last updated:
Abstract:
The present application provides dihydropyrido[2,3-d]pyrimidone inhibitors of cyclin-dependent kinase 2 (CDK2), as well as pharmaceutical compositions thereof, and methods of treating cancer using the same.
Status:
Application
Type:
Utility
Filling date:
10 Jun 2021
Issue date:
13 Jan 2022